GO
Loading...

Questcor Pharmaceuticals Inc

More

  • MS drug sales drive Questcor profit Thursday, 24 Jul 2014 | 9:28 AM ET

    July 24- Questcor Pharmaceuticals Inc posted a 39.5 percent rise in quarterly profit, helped by strong sales of multiple sclerosis drug Acthar. The company's net income rose to $96.4 million, or $1.54 per share, in the second quarter ended June 30, from $69.1 million, or $1.12 per share, a year earlier. Revenue jumped 51 percent to $278.8 million.

  • FACTBOX-M&A frenzy transforming global pharma Monday, 14 Jul 2014 | 9:27 AM ET

    July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.

  • Aging stinks, so at least make some money from it Monday, 23 Jun 2014 | 8:00 AM ET

    The US population is getting grayer, and while getting old stinks, there are plenty of ways to profit from an aging demographic using ETFs.

  • Mallinckrodt buys Questcor for about $5.2 billion Monday, 7 Apr 2014 | 8:39 AM ET

    In order to diversify its business, Ireland's Mallinckrodt is buying California-based Questcor Pharmaceuticals in a deal reaching $5.2 billion.

  • Early movers: QCOR, SYMC, GM, UA & more Monday, 7 Apr 2014 | 7:48 AM ET
    Traders work on the floor of the New York Stock Exchange during early trading on December 16, 2013 in New York City.

    Some of the names on the move ahead of the open.

  • Lightning Round: Splunk, GLD & More Monday, 3 Mar 2014 | 6:38 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Midday movers: Infosys, Sprint, Telsa & more Wednesday, 30 Oct 2013 | 12:41 PM ET

    Take a look at some of Wednesday's midday movers:

  • Lightning Round: GM, Take-Two & More Wednesday, 28 Aug 2013 | 6:45 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Video: Cramer's six stocks in 60 seconds Wednesday, 31 Jul 2013 | 10:41 AM ET

    CNBC's Jim Cramer has six stock calls in sixty seconds (or so.)

  • After-hours buzz: Amgen, Aflac, Symantec & More Tuesday, 30 Jul 2013 | 4:59 PM ET

    Check out which companies are making headlines after the bell Tuesday:

  • After-Hours Buzz: DWA, WU, QCOR & More Tuesday, 30 Apr 2013 | 5:07 PM ET

    Check out which companies are making headlines after the bell Tuesday:

  • Lightning Round: Valero, ArcelorMittal & More Wednesday, 6 Mar 2013 | 6:46 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: Exelon, Lowe’s & More Tuesday, 8 Jan 2013 | 6:39 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • After-Hours Buzz: GRPN, YUM, ZUMZ & More Thursday, 29 Nov 2012 | 5:03 PM ET

    Check out which companies are making headlines after the bell Thursday:

  • Questcor rises after hedge fund discloses stake Tuesday, 16 Oct 2012 | 2:23 PM ET

    NEW YORK-- Share of Questcor Pharmaceuticals Inc. climbed Tuesday after the hedge fund Deerfield Management Co. disclosed a stake in the beleaguered company. THE SPARK: Deerfield President James Flynn disclosed ownership of 3.5 million Questcor shares, or a 5.8 percent stake in the Anaheim, Calif., drugmaker.

  • Movers roundup: Questcor, Penn Virginia Tuesday, 9 Oct 2012 | 2:16 PM ET

    Among the stock activity stories for Tuesday, Oct. 9, from AP Business News:. _ Shares of Questcor Pharmaceuticals Inc., which had lost 60 percent of their value in the last four weeks, recovered some lost ground Tuesday after a Jefferies& Co. analyst upgraded the biopharmaceutical company's stock.

  • Midday Movers: AAPL, LLY, INTC & More Tuesday, 9 Oct 2012 | 12:37 PM ET

    Take a look at some of Tuesday's midday movers:

  • BRIEF-Questcor ships 1,740 vials of Acthar in Sept Tuesday, 9 Oct 2012 | 7:10 AM ET

    Oct 9- Questcor Pharmaceuticals Inc:. *Says during September 2012, it shipped a total of 1,740 vials of acthar to. *Source text* Further company coverage ().

  • *Jefferies raises Questcor Pharmaceuticals Inc to buy from hold;. price target to $28 from $24. *Jefferies cuts Optimer Pharmaceuticals Inc price target to $16 from.

  • Questcor Pharma rises following upgrade Tuesday, 9 Oct 2012 | 12:23 AM ET

    NEW YORK-- Shares of Questcor Pharmaceuticals Inc., which had lost 60 percent of their value in the last four weeks, recovered some lost ground Tuesday after a Jefferies& Co. analyst upgraded the stock. Amin raised his rating to "Buy" from "Hold" and increased his price target to $28 per share from $24.